Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival

Statin therapy is associated with a 5-year survival benefit after infrainguinal bypass in patients with CLI. However, 1-year limb-related outcomes were not influenced by statin use in our large observational cohort of patients undergoing revascularization in New England.